Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
663 companies reporting in the next 90 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Thursday, Nov 5 · in 70 days · 100 companies | |||||
| BLLN | BillionToOne, Inc. | Healthcare | $4.54B | −28.00% | |
| ICUI | ICU Medical, Inc. | Healthcare | $4.49B | +8.33% | |
| CON | Concentra Group Holdings Parent, Inc. | Healthcare | $4.44B | +6.91% | |
| DOCS | Doximity, Inc. | Healthcare | $4.41B | +15.39% | |
| RLAY | Relay Therapeutics, Inc. | Healthcare | $4.26B | +6.40% | |
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| INDV | Indivior Pharmaceuticals, Inc. | Healthcare | $4.23B | −12.60% |
| AMLX | Amylyx Pharmaceuticals, Inc. | Healthcare | $4.13B | +89.67% |
| IRTC | iRhythm Holdings, Inc. | Healthcare | $4.06B | +1.52% |
| DNLI | Denali Therapeutics Inc. | Healthcare | $3.98B | +2.16% |
| IOVA | Iovance Biotherapeutics, Inc. | Healthcare | $3.66B | +71.91% |
| GPCR | Structure Therapeutics Inc. | Healthcare | $3.56B | +3.05% |
| PLSE | Pulse Biosciences, Inc. | Healthcare | $3.43B | +35.61% |
| IMNM | Immunome, Inc. | Healthcare | $3.34B | +23.82% |
| MRVI | Maravai LifeSciences Holdings, Inc. | Healthcare | $3.30B | +29.74% |
| MBX | MBX Biosciences, Inc. | Healthcare | $3.22B | +11.16% |
| IRON | Disc Medicine, Inc. | Healthcare | $3.17B | +10.74% |
| WRBY | Warby Parker Inc. | Healthcare | $3.15B | −2.00% |
| AVAH | Aveanna Healthcare Holdings Inc. | Healthcare | $2.97B | +37.71% |
| BKD | Brookdale Senior Living Inc. | Healthcare | $2.91B | −20.62% |
| VRDN | Viridian Therapeutics, Inc. | Healthcare | $2.75B | +24.35% |
| PRVA | Privia Health Group, Inc. | Healthcare | $2.71B | −15.14% |
| VERA | Vera Therapeutics, Inc. | Healthcare | $2.65B | +10.50% |
| RAPP | Rapport Therapeutics, Inc. | Healthcare | $2.52B | +25.12% |
| PBH | Prestige Consumer Healthcare Inc. | Healthcare | $2.47B | +0.83% |
| ALMR | Alamar Biosciences, Inc. | Healthcare | $2.36B | +37.92% |
| URGN | UroGen Pharma Ltd. | Healthcare | $2.25B | +12.38% |
| XRAY | DENTSPLY SIRONA Inc. | Healthcare | $2.18B | −18.98% |
| VCEL | Vericel Corporation | Healthcare | $2.17B | −9.14% |
| ZYME | Zymeworks Inc. | Healthcare | $2.10B | +29.61% |
| GENB | Generate Biomedicines, Inc. | Healthcare | $2.07B | +22.83% |
| PGNY | Progyny, Inc. | Healthcare | $1.98B | −14.27% |
| ASTH | Astrana Health, Inc. | Healthcare | $1.92B | +1.69% |
| NTLA | Intellia Therapeutics, Inc. | Healthcare | $1.89B | +21.12% |
| DMRA | Damora Therapeutics, Inc. | Healthcare | $1.89B | +3.30% |
| BLFS | BioLife Solutions, Inc. | Healthcare | $1.82B | +15.70% |
| LMAT | LeMaitre Vascular, Inc. | Healthcare | $1.81B | −22.18% |
| FTRE | Fortrea Holdings Inc. | Healthcare | $1.76B | −10.48% |
| MAZE | Maze Therapeutics, Inc. | Healthcare | $1.69B | +6.10% |
| XERS | Xeris Biopharma Holdings, Inc. | Healthcare | $1.58B | +5.34% |
| TRAX | First Tracks Biotherapeutics, Inc. | Healthcare | $1.58B | +5.59% |
| NVAX | Novavax, Inc. | Healthcare | $1.52B | +24.97% |
| REPL | Replimune Group, Inc. | Healthcare | $1.50B | +196.82% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | Healthcare | $1.49B | +20.33% |
| CGEM | Cullinan Therapeutics, Inc. | Healthcare | $1.48B | +30.80% |
| OMDA | Omada Health, Inc. | Healthcare | $1.47B | +17.28% |
| NUTX | Nutex Health Inc. | Healthcare | $1.34B | +31.46% |
| AORT | Artivion, Inc. | Healthcare | $1.33B | +0.70% |
| AMN | AMN Healthcare Services, Inc. | Healthcare | $1.33B | −1.30% |
| SANA | Sana Biotechnology, Inc. | Healthcare | $1.25B | +26.44% |
| CERT | Certara, Inc. | Healthcare | $1.24B | +3.92% |
| ODTX | Odyssey Therapeutics, Inc. | Healthcare | $1.23B | +39.01% |
| GLUE | Monte Rosa Therapeutics, Inc. | Healthcare | $1.23B | −34.75% |
| JANX | Janux Therapeutics, Inc. | Healthcare | $1.15B | +25.93% |
| LXRX | Lexicon Pharmaceuticals, Inc. | Healthcare | $1.04B | −1.28% |
| QDEL | QuidelOrtho Corporation | Healthcare | $1.02B | −10.56% |
| PCRX | Pacira BioSciences, Inc. | Healthcare | $1.02B | −3.39% |
| DSGN | Design Therapeutics, Inc. | Healthcare | $975.65M | +31.34% |
| AMPH | Amphastar Pharmaceuticals, Inc. | Healthcare | $934.98M | +9.28% |
| ACRS | Aclaris Therapeutics, Inc. | Healthcare | $911.16M | +16.14% |
| SGP | SpyGlass Pharma, Inc. | Healthcare | $891.05M | +23.22% |
| COLL | Collegium Pharmaceutical, Inc. | Healthcare | $852.79M | −23.37% |
| ACHV | Achieve Life Sciences, Inc. | Healthcare | $851.00M | +33.82% |
| CTMX | CytomX Therapeutics, Inc. | Healthcare | $723.43M | +3.11% |
| GYRE | Gyre Therapeutics, Inc. | Healthcare | $705.12M | +11.02% |
| ALLO | Allogene Therapeutics, Inc. | Healthcare | $704.80M | +22.89% |
| TECX | Tectonic Therapeutic, Inc. | Healthcare | $703.19M | +20.70% |
| CTEV | Claritev Corporation | Healthcare | $636.72M | +65.73% |
| ALT | Altimmune, Inc. | Healthcare | $604.95M | +5.35% |
| RGNX | REGENXBIO Inc. | Healthcare | $588.18M | −2.29% |
| WEAV | Weave Communications, Inc. | Healthcare | $584.79M | +6.10% |
| EVH | Evolent Health, Inc. | Healthcare | $556.25M | +31.55% |
| CERS | Cerus Corporation | Healthcare | $552.18M | −6.16% |
| CCCC | C4 Therapeutics, Inc. | Healthcare | $521.63M | +19.44% |
| DNA | Ginkgo Bioworks Holdings, Inc. | Healthcare | $507.75M | −6.10% |
| CLPT | ClearPoint Neuro, Inc. | Healthcare | $499.35M | +12.66% |
| PACB | Pacific Biosciences of California, Inc. | Healthcare | $484.90M | +12.23% |
| OCGN | Ocugen, Inc. | Healthcare | $478.15M | +13.71% |
| PBYI | Puma Biotechnology, Inc. | Healthcare | $472.84M | +14.93% |
| SGHT | Sight Sciences, Inc. | Healthcare | $458.33M | +57.92% |
| BIOA | BioAge Labs, Inc. | Healthcare | $451.63M | −55.11% |
| CARL | Carlsmed, Inc. | Healthcare | $441.76M | +31.44% |
| CMPX | Compass Therapeutics, Inc. | Healthcare | $437.61M | +19.12% |
| LRMR | Larimar Therapeutics, Inc. | Healthcare | $432.15M | +8.88% |
| XFOR | X4 Pharmaceuticals, Inc. | Healthcare | $412.45M | +6.11% |
| RCKT | Rocket Pharmaceuticals, Inc. | Healthcare | $401.78M | +16.56% |
| FHTX | Foghorn Therapeutics Inc. | Healthcare | $397.29M | +30.41% |
| TKNO | Alpha Teknova, Inc. | Healthcare | $387.63M | +41.85% |
| AGEN | Agenus Inc. | Healthcare | $371.33M | +25.00% |
| RCEL | AVITA Medical, Inc. | Healthcare | $327.52M | +129.72% |
| OBIO | Orchestra BioMed Holdings, Inc. | Healthcare | $316.15M | +36.27% |
| RNAC | Cartesian Therapeutics, Inc. | Healthcare | $308.30M | +33.20% |
| TMCI | Treace Medical Concepts, Inc. | Healthcare | $306.96M | +17.71% |
| TRDA | Entrada Therapeutics, Inc. | Healthcare | $296.70M | +20.07% |
| NMRA | Neumora Therapeutics, Inc. | Healthcare | $293.12M | −7.14% |
| LCTX | Lineage Cell Therapeutics, Inc. | Healthcare | $283.26M | +4.67% |
| SION | Sionna Therapeutics, Inc. | Healthcare | $282.58M | −86.75% |
| WHWK | Whitehawk Therapeutics, Inc. | Healthcare | $275.92M | +31.52% |
| IVVD | Invivyd, Inc. | Healthcare | $265.78M | +52.06% |
| ALEC | Alector, Inc. | Healthcare | $263.51M | +61.84% |
| ORGO | Organogenesis Holdings Inc. | Healthcare | $225.18M | −30.83% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.